Literature DB >> 21422812

MDM4 downregulates p53 transcriptional activity and response to stress during differentiation.

Sergio Ménendez1, Amanda M Goh, Suzanne Camus, Kee Woei Ng, Nelly Kua, Vinay Badal, David P Lane.   

Abstract

Embryonic stem (ES) cells are invaluable for their therapeutic potential as well as for the study of early development. Their clinical use demands an understanding of ES cell differentiation, particularly with respect to cell proliferation and the maintenance of genomic integrity, processes for which the transcription factor p53 is essential. However, although the function of p53 as a tumor suppressor has been extensively studied, its role in ES cell biology has not been clearly elucidated. To study p53 activity and regulation in differentiating ES cells, we used knock-in constructs to create a novel reporter system that provides a direct readout of p53 transcriptional activity. We thereby determine that the p53 pathway is active in ES cells, but that p53 activity and the p53-dependent stress response decrease upon differentiation. Although p53 protein levels and activity are usually primarily controlled by the ubiquitin ligase MDM2, we identify the MDM2 homolog MDM4 as the key modulator of p53 activity in differentiating ES cells. Our results provide a better understanding of ES cell regulation and could help to optimize ES cell differentiation protocols for their use in regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422812     DOI: 10.4161/cc.10.7.15090

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity.

Authors:  Amanda M Goh; Chin Yan Lim; Poh Cheang Chiam; Ling Li; Michael B Mann; Karen M Mann; Sergio Menendez; David P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.

Authors:  Richard L Bennett; Yu Pan; Jaime Christian; Teng Hui; W Stratford May
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Role of an MDM4 polymorphism in the early age of onset of nasopharyngeal carcinoma.

Authors:  Yao Wei Zhang; Jian Guan; Yong Zhang; Yu Rong Qiu; Long Hua Chen
Journal:  Oncol Lett       Date:  2012-03-02       Impact factor: 2.967

4.  p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.

Authors:  Benjamin T Spike; Geoffrey M Wahl
Journal:  Genes Cancer       Date:  2011-04

Review 5.  Targeting p53-MDM2-MDMX loop for cancer therapy.

Authors:  Qi Zhang; Shelya X Zeng; Hua Lu
Journal:  Subcell Biochem       Date:  2014

Review 6.  Regulation of p53: a collaboration between Mdm2 and Mdmx.

Authors:  Dongsheng Pei; Yanping Zhang; Junnian Zheng
Journal:  Oncotarget       Date:  2012-03

7.  Embryonic stem cells shed new light on the developmental roles of p53.

Authors:  Min Hwa Shin; Yunlong He; Jing Huang
Journal:  Cell Biosci       Date:  2013-10-09       Impact factor: 7.133

8.  p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53.

Authors:  H Yan; V Solozobova; P Zhang; O Armant; B Kuehl; G Brenner-Weiss; C Blattner
Journal:  Cell Death Dis       Date:  2015-02-26       Impact factor: 8.469

9.  Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice.

Authors:  Amanda M Goh; Yuezhen Xue; Marc Leushacke; Ling Li; Julin S Wong; Poh Cheang Chiam; Siti Aishah Binte Rahmat; Michael B Mann; Karen M Mann; Nick Barker; Guillermina Lozano; Tamara Terzian; David P Lane
Journal:  Oncotarget       Date:  2015-07-20

10.  Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells.

Authors:  Yoko Itahana; Jinqiu Zhang; Jonathan Göke; Leah A Vardy; Rachel Han; Kozue Iwamoto; Engin Cukuroglu; Paul Robson; Mahmoud A Pouladi; Alan Colman; Koji Itahana
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.